Suraksha Diagnostic Ltd. was incorporated on March 15, 2005. It is a full-service and integrated diagnostic chain headquartered in East India. The company offers a one-stop integrated solution for pathology and radiology testing, and medical consultation services to its customers.
| Bidding Dates |
|---|
| 29 Nov 2024 - 03 Dec 2024 |
| Subscription |
|---|
| 1.27x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹14,280 | 1 | 13 | 34 | 19.2 M | ₹420 - ₹441 | 48.78 % | ₹8059.5 M - ₹8462.5 M | RHP DOC |
Suraksha Diagnostic Ltd. IPO SUBSCRIPTION STATUS
03 Dec '24Suraksha Diagnostic Ltd. IPO overall subscription rate was 1.27 times the total available shares
Suraksha Diagnostic Ltd. IPO retail subscription rate was 0.95 times in the retail segment
Suraksha Diagnostic Ltd. IPO non-institutional investor subscription rate was 1.41 times in the non-institutional investor category
Suraksha Diagnostic Ltd. IPO Qualified Institutional Bidder subscription rate was 1.74 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
03 Dec 2024 (Day 3) | 0.95x | 1.41x | 1.74x |
02 Dec 2024 (Day 2) | 0.45x | 0.13x | 0x |
29 Nov 2024 (Day 1) | 0.2x | 0.04x | - |
Suraksha Diagnostic Ltd. FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) | Margins |
| Q1FY25 | 76.7 | 607.3 | 183.5 | 109.1 | 35.8% |
| FY24 | 231.3 | 2,187.1 | 604.8 | 175.6 | 33.7% |
| FY23 | 60.7 | 1,901.3 | 441.0 | 315.9 | 25.0% |
| FY22 | 208.2 | 2,231.9 | 578.2 | 389.2 | 29.2% |
Suraksha Diagnostic Ltd. IPO SUBSCRIPTION STATUS DETAILS
Suraksha Diagnostic Ltd. had 19.2 M shares on offer
Suraksha Diagnostic Ltd. IPO offer price was in the range ₹420 - ₹441
Suraksha Diagnostic Ltd. IPO minimum Investment was ₹14280
Suraksha Diagnostic Ltd. IPO issue size was ₹ 8059.5 M - ₹ 8462.5 M
Suraksha Diagnostic Ltd. had a minimum lot size of 34 Shares per application
Suraksha Diagnostic Ltd. NUMBER OF SHARES ON OFFER
Suraksha Diagnostic Ltd. IPO IMPORTANT DATES
| Issue Open Date | 29 Nov 2024 |
| Issue close Date | 03 Dec 2024 |
| Allotment Date | 04 Dec 2024 |
| Refund Date | 05 Dec 2024 |
| Demat Account Credit Date | 05 Dec 2024 |
| Listing Date | 06 Dec 2024 |
| Listing on Exchange(s) | NSE and BSE |
| Suraksha Diagnostic Ltd. Allotment Status | Exchange |
Suraksha Diagnostic Ltd. IPO subscription opened on 29 Nov 2024, and closed on 03 Dec 2024
IPO allotment for Suraksha Diagnostic Ltd. was finalized on Wednesday, 04 Dec 2024
IPO listing for Suraksha Diagnostic Ltd. was on NSE and BSE on Friday, 06 Dec 2024
Suraksha Diagnostic Ltd. IPO LISTING GAINS
| Issue Price (adjusted) | 441.0 |
| Listing Open Price | 438.0 |
| Listing Close Price | 417.3 |
| Listing Gain% | -0.7% |
| Current Gain% | -39.8% |
Suraksha Diagnostic Ltd. Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Suraksha Diagnostic Ltd. | 265.5 | 1382.7 | 43 | 37.7 | 4.5 | 13.1 | 7.2 | 313.6 | 22.5 | 32.2 | 1.1 | 6.2 | 1.1 |
| Dr. Lal Pathlabs Ltd. | 1954 | 32797.7 | 60.5 | 10.8 | 11.3 | 20.1 | 16 | 2864.2 | 12.1 | 504.8 | 3.6 | 32.3 | 5.6 |
| Inventurus Knowledge Solutions Ltd. | 1728.8 | 29661.6 | 38.8 | 0.9 | 8.9 | 25.8 | 16.9 | 3211 | 18.8 | 721.6 | 48.4 | 44.5 | 40.9 |
| Vijaya Diagnostic Centre Ltd. | 1392.6 | 14343.5 | 76.5 | 3.1 | 16.7 | 18.1 | 11.5 | 835 | 19.3 | 173 | 20.9 | 18.2 | 24.9 |
| Indegene Ltd. | 568.8 | 13702 | 34.2 | -4.3 | 3.6 | 12.8 | 8.7 | 3582.5 | 21.6 | 401.1 | -1.4 | 16.6 | -7.9 |
| Metropolis Healthcare Ltd. | 572.6 | 11876.1 | 58.9 | 1.8 | 6.9 | 12.6 | 8.9 | 1671.4 | 24.1 | 190 | 31.1 | 9.7 | 32.6 |
Suraksha Diagnostic Ltd. INFORMATION ON IPO ISSUE
About Suraksha Diagnostic Ltd.
Suraksha Diagnostic Ltd. was incorporated on March 15, 2005. It is a full-service and integrated diagnostic chain headquartered in East India. The company offers a one-stop integrated solution for pathology and radiology testing, and medical consultation services to its customers.
Object of the Issue
- To carry out the offer for sale of up to 19,189,330 equity shares by the selling shareholders
- To achieve the benefits of listing the equity shares on the stock exchanges
Suraksha Diagnostic Ltd. - PROMOTERS
| Name |
|---|
| Somnath Chatterjee |
| Ritu Mittal |
| Satish Kumar Verma |
Suraksha Diagnostic Ltd. Book Running Lead Managers
ICICI Securities Limited
Surakshaipo@icicisecurities.com
Nuvama Wealth Management Limited
suraksha.ipo@nuvama.com
SBI Capital Markets Limited
suraksha.ipo@sbicaps.com
Suraksha Diagnostic Ltd. Registrar to the Offer
KFin Technologies Limited
sdl.ipo@kfintech.com
Suraksha Diagnostic Ltd. Strengths
Dominant Position
The company is the largest full-service and integrated diagnostic chain with a dominant position in eastern India well positioned to leverage high growth opportunities for organised diagnostic chains in the fragmented diagnostic services markets in eastern and north-eastern India
Relationship with customers
The company has a high brand recall and commitment to a superior quality driving high individual consumer business share and customer retention
Suraksha Diagnostic Ltd. Risks
Geographically concentrated
The company's operations are concentrated in West Bengal and the eastern region of India, and any loss of business in such region could have an adverse effect on its business, results of operations, and financial condition
Depenedent on third-party
The company depends on third-party vendors and suppliers to provide them with testing equipment, test kits, and reagents, and any failure in procuring such equipment or recall of existing testing equipment, kits, and reagents could adversely affect its financial condition
Faces competition
The diagnostics industry in India is highly competitive. The company's competitors include other diagnostic chains, such as Vijaya Diagnostic Centre, Agilus Diagnostics, and Dr. Lal Pathlabs. Its inability to compete effectively with other healthcare service providers may adversely affect the business
IPO FAQs
This IPO consists of an offer for sale of up to Rs 846.2 crore, of 19,189,330 shares.
The promoters of the company are Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 420.0 - 441.0.
The IPO application opens on Nov 29, 2024 and closes on Dec 03, 2024.
The minimum lot size for the IPO is 34. The maximum lot size for the IPO is 442.
For all category investors, the minimum application amount for this IPO is Rs. 14,280.0, the maximum value for this IPO is Rs 194,922.0.
This IPO will be allotted on Dec 04, 2024.
The refund will be credited to your account on Dec 05, 2024.
The allotted shares will be credited to your demat on Dec 05, 2024.
Suraksha Diagnostic Ltd.’s shares listed on the stock exchanges on Dec 06, 2024.